View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
August 31, 2017

M&As this week: Merck KGaA, Genius Lead, Sanofi

German science and technology company Merck KGaA plans to acquire Canadian hydrogel membrane products provider Natrix Separations.

German science and technology company Merck KGaA plans to acquire Canadian hydrogel membrane products provider Natrix Separations.

The acquisition strengthens Merck’s mAb and vaccine manufacturing capabilities.

Healthcare services provider Genius Lead plans to acquire 11% stake in pharmaceutical product developer Rui Kang Pharmaceutical Group Investments from Chinese pharmaceutical distributor New Ray Medicine International Holding for HK$44.21m ($5.64m).

Both Genius Lead and Rui Kang are based in Hong Kong.

"Sanofi has announced the acquisition of US-based biotechnology company Protein Sciences for $750m."

Sanofi has announced the acquisition of US-based biotechnology company Protein Sciences for $750m.

The acquisition will enable the French pharmaceutical company to expand its influenza vaccine portfolio.

Chinese biotechnology company Guangdong VTR BioTech has announced the acquisition of a 15.2% stake in a biotechnology company based in Hunan for CNY38.1m ($5.74m).

The transaction increases Guangdong VTR Bio-Tech’s stake in the entity from 75% to 90.2%.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU